SSRI bleeding risk (platelet dysfunction)

Mechanism

Platelets do not synthesize serotonin. They take it up from plasma using SERT (the same serotonin transporter that neurons use). SSRIs block SERT. Over weeks of treatment, platelet serotonin stores deplete.

Serotonin is one of the key signals platelets release when they aggregate at a bleeding site. Serotonin-depleted platelets aggregate less effectively. The functional effect is similar to a low dose of aspirin.

SNRIs cause a similar but smaller effect. Non-serotonergic antidepressants (bupropion, mirtazapine) do not have this platelet effect.

Which patients are at highest risk

Baseline population: young healthy adult on SSRI monotherapy. Absolute increased risk is very small.

Moderate risk:

• Age above 60
• Concurrent NSAID use (see our SSRI plus NSAIDs page)
• Concurrent low-dose aspirin
• History of GI ulcer
• H. pylori infection

High risk:

• Concurrent anticoagulation (warfarin, DOACs)
• Recent GI bleeding
• Cirrhosis or portal hypertension
• Recent GI or peritoneal surgery
• Prior intracranial hemorrhage

What bleeds

GI bleeding: Upper GI (peptic ulcer, esophageal, gastric) is most common. Lower GI bleeding (diverticular, colonic) also increased.

Intracranial hemorrhage: Modestly increased risk, particularly in patients with hypertension, anticoagulation, or prior cerebrovascular disease.

Perioperative bleeding: Modestly increased transfusion requirements in major surgery. Effect is small.

Menstrual bleeding: Heavier and longer menses on SSRIs in some women.

Postpartum bleeding: Modestly increased risk.

Bruising: More frequent bruising on SSRIs is common, usually benign.

Management

For patients starting an SSRI:

• Discuss NSAID avoidance
• Screen for anticoagulant use
• Screen for ulcer history

For patients on SSRI with pain needs:

• Acetaminophen first-line
• Topical NSAIDs if oral needed
• Suzetrigine for acute pain (Journavx)

For patients on SSRI plus anticoagulation:

• Consider PPI addition
• Consider non-SSRI antidepressant (bupropion, mirtazapine)
• Regular INR monitoring for warfarin
• Adequate GI evaluation for symptoms

For patients with new GI bleeding on SSRI:

• Evaluate bleeding source
• Consider switching to non-SSRI antidepressant
• H. pylori testing
• PPI

Perioperative:

• Most surgeries do not require SSRI discontinuation
• High-bleed-risk procedures (cardiac, intracranial) may warrant preoperative discussion
• Do not stop abruptly; risk of discontinuation syndrome and depression recurrence
• Restart post-op as soon as oral intake tolerated

Common questions

Should I stop my SSRI before surgery? Usually no. Most surgeries do not require SSRI discontinuation. Major cardiac or intracranial surgery may warrant preoperative discussion.

Does the bleeding risk go away when I stop the SSRI? Yes, over 1 to 2 weeks after stopping as platelet turnover restores serotonin stores.

Which SSRI has the least bleeding risk? All SSRIs cause similar platelet dysfunction. Escitalopram may have modestly less effect than paroxetine or fluoxetine, but differences are small. Bupropion and mirtazapine (non-serotonergic) have no significant bleeding effect.

Should I avoid ibuprofen entirely on my SSRI? For occasional short-term use in a healthy adult, occasional ibuprofen is acceptable. For regular use or in higher-risk patients, acetaminophen is safer.

What about aspirin for cardiovascular prevention? The added bleeding risk of SSRI plus low-dose aspirin is small in absolute terms. For most patients, the cardiovascular benefit of aspirin outweighs the small added bleeding risk. Individual balance with primary care.

Can I donate blood on an SSRI? Yes. SSRI use does not disqualify blood donation. The mild platelet effect does not affect blood product utility.

Should I get an endoscopy before starting an SSRI? No, not routinely. Screening endoscopy is not warranted for asymptomatic SSRI initiation. For patients with prior ulcer disease or ongoing symptoms, evaluation before treatment is reasonable.